Integrated Programs enabled by Translational Pharmaceutics at Quotient Sciences

DCAT Week New York 2026

New York, United States | 23 March 2026 - 26 March 2026
Overview

Connect with Quotient Sciences’ experts who will be attending DCAT Week taking place in New York 23rd – 26th of March 2026. 

DCAT Week is the premier global event held each year in New York City for companies engaged in the Bio/Pharmaceutical business ecosystem.  

You can schedule a partnering meeting with our experts by using the button below. 

Request a meeting with us:
Location
The Fifty Sonesta Select
155 E 50th St., NY 10022
New York, United States

Meet our experts:

We look forward to meeting you at the DCAT Week this March.

Thierry Van Nieuwenhove

CEO

Thierry Van Nieuwenhove, CEO, joined Quotient Sciences in October 2023. He succeeds Mark Egerton as CEO, who retired after 18 year...

About Thierry
Eric Bironneau

Chief Business Officer

Eric Bironneau has joined the company as Chief Business Officer, with responsibility for Quotient Sciences’ commercial organizatio...

About Eric
Dr. Andrew Lewis

Chief Scientific Officer

Dr. Andrew (Andy) Lewis is the Chief Scientific Officer at Quotient Sciences. As the leader of Quotient Sciences' scientific teams...

About Andrew
Matt Paterson

Chief Strategy Officer, Directors

Matt Paterson is Chief Strategy Officer at Quotient Sciences. With over 27 years of global experience in the pharmaceutical indust...

About Alyson
Dr. Vanessa Zann

VP, Scientific Consulting, Translational Pharmaceutics & Clinical Pharmacology - USA

Dr. Vanessa Zann has over twenty-five years industry experience providing expert biopharmaceutic support to drug discovery, early ...

About Vanessa
Dr. Asma Patel

VP, Integrated Development Services

Dr. Asma Patel is responsible for providing scientific and technical support to Quotient Sciences' business development group and ...

About Asma
Katie Stuart

Executive Director & Head of Commercial TP-CP USA

Katie Stuart brings 27 years of experience in the pharmaceutical industry, with a background spanning analytical chemistry and bus...

About Katie
Daniel Dennehy

Director, Business Development

Daniel Dennehy is an accomplished Business Development Director with over 10 years’ experience in sales to healthcare, pharmaceuti...

About Daniel
Nabil Lally

Senior Director, Business Development

Nabil Lally's tenure at Quotient Sciences is marked by pioneering the Translational Pharmaceutics platform, delivering an average ...

About Nabil
Jennifer Lattimer

Executive Director & Head of Global Inside Sales Management

Jennifer Lattimer is a motivated, outgoing and experienced Sales Executive with a demonstrated history of global business closure,...

About Jennifer

More insight from our experts:

Read More
Drug Product, Commercial Manufacturing, Clinical Trial Manufacturing, Translational Pharmaceutics, Regulatory, Orphan Rare, FDA Navigating Expedited Drug Development Pathways Globally: Q&A with Quotient Sciences Experts
Read More
Pediatrics, Formulation Development, Drug Product A Comprehensive Approach to Pediatric Drug Products: Q&A with Nazim Kanji
Read More
Drug Development Consulting, Translational Pharmaceutics, Formulation Development, Drug Product, Careers The Strategic Role of Drug Development Consultants at Quotient Sciences
Read More
Read More